ReP USP - Resultado da busca

Artigo de periodico
Plasmodial transcription factors and chromatin modifiers as drug targets (2024)
Sepulveda, Luisa Fernanda Ortega; Oliveira, Gabriela Mendes de; Chagas, Elaine Hellen Nunes ; Wild, Nele ; Paz, Franciarli ; Wrenger, Carsten ; Wunderlich, Gerhard
Source: Future Pharmacology. Unidade: ICB
Subjects: PARASITOLOGIA, CROMATINA, EXPRESSÃO GÊNICA, PLASMODIUM FALCIPARUM, TRANSCRIÇÃO GÊNICA, ANTIMALÁRICOS, TRANSFERASES, ANIMAIS PARASITOS, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEPULVEDA, Luisa Fernanda Ortega et al. Plasmodial transcription factors and chromatin modifiers as drug targets. Future Pharmacology, v. 3, n. 4, p. 846-861, 2024Tradução . . Disponível em: https://doi.org/10.3390/futurepharmacol3040051. Acesso em: 05 nov. 2024.
APA
Sepulveda, L. F. O., Oliveira, G. M. de, Chagas, E. H. N., Wild, N., Paz, F., Wrenger, C., & Wunderlich, G. (2024). Plasmodial transcription factors and chromatin modifiers as drug targets. Future Pharmacology, 3( 4), 846-861. doi:10.3390/futurepharmacol3040051
NLM
Sepulveda LFO, Oliveira GM de, Chagas EHN, Wild N, Paz F, Wrenger C, Wunderlich G. Plasmodial transcription factors and chromatin modifiers as drug targets [Internet]. Future Pharmacology. 2024 ; 3( 4): 846-861.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/futurepharmacol3040051
Vancouver
Sepulveda LFO, Oliveira GM de, Chagas EHN, Wild N, Paz F, Wrenger C, Wunderlich G. Plasmodial transcription factors and chromatin modifiers as drug targets [Internet]. Future Pharmacology. 2024 ; 3( 4): 846-861.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/futurepharmacol3040051
Artigo de periodico
Antimicrobial peptides and their assemblies (2023)
Carmona-Ribeiro, Ana Maria
Source: Future Pharmacology. Unidade: IQ
Subjects: PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARMONA-RIBEIRO, Ana Maria. Antimicrobial peptides and their assemblies. Future Pharmacology, v. 3, p. 763–788, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/futurepharmacol3040047. Acesso em: 05 nov. 2024.
APA
Carmona-Ribeiro, A. M. (2023). Antimicrobial peptides and their assemblies. Future Pharmacology, 3, 763–788. doi:10.3390/futurepharmacol3040047
NLM
Carmona-Ribeiro AM. Antimicrobial peptides and their assemblies [Internet]. Future Pharmacology. 2023 ; 3 763–788.[citado 2024 nov. 05 ] Available from: https://dx.doi.org/10.3390/futurepharmacol3040047
Vancouver
Carmona-Ribeiro AM. Antimicrobial peptides and their assemblies [Internet]. Future Pharmacology. 2023 ; 3 763–788.[citado 2024 nov. 05 ] Available from: https://dx.doi.org/10.3390/futurepharmacol3040047
Artigo de periodico
Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia (2021)
Barbosa, Bárbara Lima Fonseca; Freitas, Tulio Resende; Almeida, Michell de Oliveira ; Araújo, Sérgio Schusterschitz da Silva; Andrade, Ana Clara; Dornelas, Geovana Gomes; Fiorotto, Julyana Gayva; Maltarollo, Vinicius Gonçalves; Sabino, Adriano de Paula
Source: Future Pharmacology. Unidade: IQSC
Subjects: LEUCEMIA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Bárbara Lima Fonseca et al. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Future Pharmacology, v. 1, p. 60–79, 2021Tradução . . Disponível em: https://doi.org/10.3390/futurepharmacol1010006. Acesso em: 05 nov. 2024.
APA
Barbosa, B. L. F., Freitas, T. R., Almeida, M. de O., Araújo, S. S. da S., Andrade, A. C., Dornelas, G. G., et al. (2021). Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Future Pharmacology, 1, 60–79. doi:10.3390/futurepharmacol1010006
NLM
Barbosa BLF, Freitas TR, Almeida M de O, Araújo SS da S, Andrade AC, Dornelas GG, Fiorotto JG, Maltarollo VG, Sabino A de P. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia [Internet]. Future Pharmacology. 2021 ;1 60–79.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/futurepharmacol1010006
Vancouver
Barbosa BLF, Freitas TR, Almeida M de O, Araújo SS da S, Andrade AC, Dornelas GG, Fiorotto JG, Maltarollo VG, Sabino A de P. Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia [Internet]. Future Pharmacology. 2021 ;1 60–79.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/futurepharmacol1010006

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects